RSS feed

Publications (original articles or review articles) published in 2024 from OUS - Department of Pharmacology

14 publications found

Abdullah R, Bjørnebekk A, Hauger LE, Hullstein IR, Edvardsen T, Haugaa KH, Almaas VM (2024)
Severe biventricular cardiomyopathy in both current and former long-term users of anabolic-androgenic steroids
Eur J Prev Cardiol, 31 (5), 599-608
DOI 10.1093/eurjpc/zwad362, PubMed 37992194

Aune A, Ohldieck A, Halvorsen LV, Brobak KM, Olsen E, Rognstad S, Larstorp ACK, Søraas CL, Rossebø AB, Rösner A, Grytaas MA, Gerdts E (2024)
Gender Differences in Cardiac Organ Damage in Arterial Hypertension: Assessing the Role of Drug Nonadherence
High Blood Press Cardiovasc Prev, 31 (2), 157-166
DOI 10.1007/s40292-024-00632-6, PubMed 38530572

Brobak KM, Halvorsen LV, Aass HCD, Søraas CL, Aune A, Olsen E, Bergland OU, Rognstad S, Blom KB, Birkeland JAK, Høieggen A, Larstorp ACK, Solbu MD (2024)
Novel biomarkers in patients with uncontrolled hypertension with and without kidney damage
Blood Press, 33 (1), 2323980
DOI 10.1080/08037051.2024.2323980, PubMed 38606688

Fjeld H, Vukovic M (2024)
How should intravenous antibiotic therapy at home be organised?
Tidsskr Nor Laegeforen, 144 (5)
DOI 10.4045/tidsskr.24.0081, PubMed 38651706

Gustavsen I, Gustavsen WR, Gajdzik T, Solyga VM (2024)
Delayed neuropsychiatric syndrome after carbon monoxide poisoning
Tidsskr Nor Laegeforen, 144 (3)
DOI 10.4045/tidsskr.23.0481, PubMed 38415575

Havig SM, Berg-Pedersen RM, Krabseth HM, Müller LD, Haugaa K, Zare HK, Gjesdal K, Krajci P, Opdal MS (2024)
Effect on QTc interval by switching from methadone to equipotent R-methadone dose in methadone maintenance treatment patients
Basic Clin Pharmacol Toxicol, 134 (4), 519-530
DOI 10.1111/bcpt.13982, PubMed 38308508

Helset E, Cheng V, Sporsem H, Thorstensen C, Nordøy I, Gammelsrud KW, Hanssen G, Ponzi E, Lipman J, von der Lippe E (2024)
Meropenem pharmacokinetic/pharmacodynamic target attainment and clinical response in ICU patients: A prospective observational study
Acta Anaesthesiol Scand, 68 (4), 502-511
DOI 10.1111/aas.14376, PubMed 38286568

Larsen RE, Hole K, Selle ML, Johannessen Landmark C, Krogstad T, Holm LB (2024)
Access to a tailored mobile application enhances medication adherence among young users of antidepressants
Front Pharmacol, 15, 1379700
DOI 10.3389/fphar.2024.1379700, PubMed 38659579

Lauritzen T, Munkhaugen J, Bergan S, Peersen K, Svarstad AC, Andersen AM, Pahnke J, Husebye E, Vethe NT (2024)
The atorvastatin metabolite pattern in muscle tissue and blood plasma is associated with statin muscle side effects in patients with coronary heart disease; An exploratory case-control study
Atheroscler Plus, 55, 31-38
DOI 10.1016/j.athplu.2024.01.001, PubMed 38293288

Levernaes MCS, Solheim SA, Broderstad L, Zandy E, Mørkeberg J, Dehnes Y (2024)
Detection of doping substances in paired dried blood spots and urine samples collected during doping controls in Danish fitness centers
Drug Test Anal (in press)
DOI 10.1002/dta.3660, PubMed 38433478

Pagnon de la Vega M, Syvänen S, Giedraitis V, Hooley M, Konstantinidis E, Meier SR, Rokka J, Eriksson J, Aguilar X, Spires-Jones TL, Lannfelt L, Nilsson LNG, Erlandsson A, Hultqvist G, Ingelsson M, Sehlin D (2024)
Altered amyloid-β structure markedly reduces gliosis in the brain of mice harboring the Uppsala APP deletion
Acta Neuropathol Commun, 12 (1), 22
DOI 10.1186/s40478-024-01734-x, PubMed 38317196

Pivoriunas J, Vethe NT, Husebye E, Fagerland MW, Bergan S, Kristiansen O, Prof JM, Sverre E (2024)
Validation of a novel direct method to determine reduced adherence to atorvastatin therapy
Eur Heart J Cardiovasc Pharmacother (in press)
DOI 10.1093/ehjcvp/pvae001, PubMed 38196131

Ulvmoen A, Greiff V, Bechensteen AG, Inngjerdingen M (2024)
NKG2A discriminates natural killer cells with a suppressed phenotype in pediatric acute leukemia
J Leukoc Biol, 115 (2), 334-343
DOI 10.1093/jleuko/qiad112, PubMed 37738462

Vethe NT, Andersen AM, Gedde-Dahl T, Büchner J, Bergan S (2024)
Therapeutic Drug Monitoring of Intravenous Busulfan and Analytical Challenges due to the Drug Formulation Excipient PEG 400: Letter to the Editor
Ther Drug Monit (in press)
DOI 10.1097/FTD.0000000000001209, PubMed 38648662